Eosinophil: A Nonnegligible Predictor in COVID-19 Re-Positive Patients

Overview of attention for article published in Frontiers in immunology, July 2021

Altmetric Badge

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 24 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 67,676 followers.

RT @FrontImmunol: New Research: Eosinophil: A Nonnegligible Predictor in COVID-19 Re-Positive Patients: Although vaccine resources are bein…

30 Jul 2021

Reply Repost Favourite

Frontiers | Eosinophil: A Nonnegligible Predictor in COVID-19 Re-Positive Patients | Immunology https://t.co/A3egzxKbf0

30 Jul 2021

Reply Repost Favourite

New Research: Eosinophil: A Nonnegligible Predictor in COVID-19 Re-Positive Patients: Although vaccine resources are being distributed worldwide, insufficient vaccine production remains a major obstacle to herd immunity. In such an… https://t.co/iBufJORgX2

29 Jul 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.